Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kamenický

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Annales D'Endocrinologie|April 24, 2012
[Treatment of acromegaly: a critical analysis of the last ten years]Philippe Chanson, Peter Kamenický
Neuroendocrinology|January 28, 2019
Growth Hormone Response to Oral Glucose Load: From Normal to Pathological ConditionsMirella Hage, Peter Kamenický, Philippe Chanson
The New England Journal of Medicine|March 26, 2015
Gigantism, acromegaly, and GPR101 mutationsPeter Kamenický, Jérôme Bouligand, Philippe Chanson
Annales D'Endocrinologie|November 10, 2020
Cardiovascular complications of acromegalyPeter Kamenický, Luigi Maione, Philippe Chanson
Annales D'Endocrinologie|January 16, 2025
Chapter 4: Differential diagnosis of primary hyperparathyroidismPeter Kamenický, Pascal Houillier, Marie-Christine Vantyghem
Annales D'Endocrinologie|May 10, 2016
Primary hyperparathyroidism in pregnancyPeter Kamenický, Anne-Lise Lecoq, Philippe Chanson
The Journal of Clinical Endocrinology and Metabolism|June 9, 2025
Cardiomyopathy in Patients With Acromegaly - Not Truly a Concern Anymore?Peter Wolf, Luigi Maione, Peter Kamenický, et al.
Archives of Medical Research|December 1, 2023
Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk FactorsPeter Wolf, Luigi Maione, Peter Kamenický, et al.
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Drug-Related HypercalcemiaAnne-Lise Lecoq, Marine Livrozet, Anne Blanchard, et al.
Lancet (London, England)|August 24, 2024
X-linked hypophosphataemiaPeter Kamenický, Karine Briot, Craig F Munns, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Annales D'Endocrinologie|April 24, 2012
[Treatment of acromegaly: a critical analysis of the last ten years]Philippe Chanson, Peter Kamenický
Neuroendocrinology|January 28, 2019
Growth Hormone Response to Oral Glucose Load: From Normal to Pathological ConditionsMirella Hage, Peter Kamenický, Philippe Chanson
The New England Journal of Medicine|March 26, 2015
Gigantism, acromegaly, and GPR101 mutationsPeter Kamenický, Jérôme Bouligand, Philippe Chanson
Annales D'Endocrinologie|November 10, 2020
Cardiovascular complications of acromegalyPeter Kamenický, Luigi Maione, Philippe Chanson
Annales D'Endocrinologie|January 16, 2025
Chapter 4: Differential diagnosis of primary hyperparathyroidismPeter Kamenický, Pascal Houillier, Marie-Christine Vantyghem
Annales D'Endocrinologie|May 10, 2016
Primary hyperparathyroidism in pregnancyPeter Kamenický, Anne-Lise Lecoq, Philippe Chanson
The Journal of Clinical Endocrinology and Metabolism|June 9, 2025
Cardiomyopathy in Patients With Acromegaly - Not Truly a Concern Anymore?Peter Wolf, Luigi Maione, Peter Kamenický, et al.
Archives of Medical Research|December 1, 2023
Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk FactorsPeter Wolf, Luigi Maione, Peter Kamenický, et al.
Endocrinology and Metabolism Clinics of North America|November 14, 2021
Drug-Related HypercalcemiaAnne-Lise Lecoq, Marine Livrozet, Anne Blanchard, et al.
Lancet (London, England)|August 24, 2024
X-linked hypophosphataemiaPeter Kamenický, Karine Briot, Craig F Munns, et al.
Pageof 8